RAP 3.33% 14.5¢ resapp health limited

Ann: Healthcare Leaders Appointed to Industry Advisory Board, page-2

  1. 2,771 Posts.
    lightbulb Created with Sketch. 286
    Tony Keating, CEO and Managing Director of ResApp commented, “As we begin the global commercialisation of our products, we are excited to announce the formation of our Industry Advisory Board. Both Dr Fried and Dr Kvedar are incredibly talented and experienced professionals who are recognised leaders in digital health and bring a vast amount of experience from within the US healthcare system. We are confident that ResApp will benefit greatly from their insights, judgment and counsel.”

watchlist Created with Sketch. Add RAP (ASX) to my watchlist
(20min delay)
Mkt cap ! $100.9M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $39.35K 269.3K

Buyers (Bids)

No. Vol. Price($)
17 415026 14.0¢

Sellers (Offers)

Price($) Vol. No.
15.0¢ 403571 7
View Market Depth
Last update - 15.49pm 24/07/2019 (20 minute delay) ?
-0.005 ( 3.45 %)
Open High Low Volume
14.5¢ 14.5¢ 14.0¢ 155241
Last updated 15.54pm 24/07/2019 (live) ?
RAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.